Circulating tumour cells-monitoring treatment response in prostate cancer. - Wikidata - wikimedia - TriplyDB

Circulating tumour cells-monitoring treatment response in prostate cancer.

Circulating tumour cells-monitoring treatment response in prostate cancer.

http://www.wikidata.org/entity/Q38211361

about

When Prostate Cancer Circulates in the Bloodstream Current Understanding of Circulating Tumor Cells - Potential Value in Malignancies of the Central Nervous System Circulating Tumor Cells: A Window Into Tumor Development and Therapeutic Effectiveness The emerging molecular machinery and therapeutic targets of metastasis Using circulating tumor cells to inform on prostate cancer biology and clinical utility Nanotechnology for enrichment and detection of circulating tumor cells.Single-Cell Analysis of Circulating Tumor Cells as a Window into Tumor Heterogeneity Categorical versus continuous circulating tumor cell enumeration as early surrogate marker for therapy response and prognosis during docetaxel therapy in metastatic prostate cancer patients Biodegradable nano-films for capture and non-invasive release of circulating tumor cells.Vimentin and Ki67 expression in circulating tumour cells derived from castrate-resistant prostate cancer.Gene expression analysis of bone metastasis and circulating tumor cells from metastatic castrate-resistant prostate cancer patients.The Use of a New CellCollector to Isolate Circulating Tumor Cells from the Blood of Patients with Different Stages of Prostate Cancer and Clinical Outcomes - A Proof-of-Concept Study.Quick chip assay using locked nucleic acid modified epithelial cell adhesion molecule and nucleolin aptamers for the capture of circulating tumor cells Dynamic monitoring of circulating tumour cells to evaluate therapeutic efficacy in advanced gastric cancer Highly efficient and selective isolation of rare tumor cells using a microfluidic chip with wavy-herringbone micro-patterned surfaces.Aneuploidy of chromosome 8 in circulating tumor cells correlates with prognosis in patients with advanced gastric cancer.Phenotypic and genetic heterogeneity of tumor tissue and circulating tumor cells in patients with metastatic castration-resistant prostate cancer: A report from the PETRUS prospective study.Circulating tumor cells and circulating tumor DNA for precision medicine: dream or reality?Nanobiotechnology for the Therapeutic Targeting of Cancer Cells in Blood.Synergistic action of image-guided radiotherapy and androgen deprivation therapy.Lectin from Sambucus sieboldiana abrogates the anoikis resistance of colon cancer cells conferred by N-acetylglucosaminyltransferase V during hematogenous metastasis.Metabolomic profiling for the identification of novel diagnostic markers in prostate cancer.Using the New CellCollector to Capture Circulating Tumor Cells from Blood in Different Groups of Pulmonary Disease: A Cohort Study.Epithelial-mesenchymal transition in prostatic disease.Molecular biomarkers to guide precision medicine in localized prostate cancer.Clinical Utility of Circulating Tumor Cells in Advanced Prostate Cancer.Regulation of prostate cancer progression by the tumor microenvironment.Cellular determinants and microenvironmental regulation of prostate cancer metastasis.Nanoelectromechanical Chip (NELMEC) Combination of Nanoelectronics and Microfluidics to Diagnose Epithelial and Mesenchymal Circulating Tumor Cells from Leukocytes.The promise of circulating tumor cells for precision cancer therapy.Melanoma antigens are biomarkers for ipilimumab response.A cancer specific hypermethylation signature of the TERT promoter predicts biochemical relapse in prostate cancer: a retrospective cohort study.Improving radiotherapy in cancer treatment: Promises and challenges.Surgical cytoreduction of the primary tumor reduces metastatic progression in a mouse model of prostate cancer.ACSL3 promotes intratumoral steroidogenesis in prostate cancer cells.A comprehensive study of circulating tumour cells at the moment of prostate cancer diagnosis: biological and clinical implications of EGFR, AR and SNPs.Precisely Enumerating Circulating Tumor Cells Utilizing a Multi-Functional Microfluidic Chip and Unique Image Interpretation Algorithm.Circulating tumor cells in genitourinary tumors.Cryopreservation for delayed circulating tumor cell isolation is a valid strategy for prognostic association of circulating tumor cells in gastroesophageal cancer.Circulating tumor cells, tumor-derived extracellular vesicles and plasma cytokeratins in castration-resistant prostate cancer patients.

P2860

Q26768470-5D6AD6CB-3D04-4F23-A3C3-6053A39BAF0F Q26796208-7CEBF19A-CE94-4C7A-8A14-352D504EE1B8 Q26827815-036EEA57-47B8-4860-BC17-3202B68B2078 Q27022207-00F28787-2998-4132-9822-45D5AA33D4BD Q28083261-1CFE1A74-5287-457A-9373-621374F3C74E Q30382502-B8C49859-B158-4BC5-8012-CA56242B35C3 Q33883227-FD2A1903-3574-41C3-9880-716083A00791 Q35655761-5ED4D522-817B-42DF-9718-B240D8FF1322 Q35682740-4F537616-8081-4F93-A839-E87A87C212D2 Q35938840-3E28D9C5-7B12-4139-9B2D-CED3028B89DA Q35956586-3702E40C-D7B1-47AC-AE70-A6CF09ECEB2D Q36091649-84687A6F-C2DF-429F-B8E6-C027B3279188 Q36117908-39674620-59A2-4B42-8F47-4D7C060AEF04 Q36750709-4BDCB64C-53AC-40E0-9819-10A26DC52EF4 Q37312795-F1883F68-D36A-4940-BFCC-DF366778C4C4 Q37592228-9957372F-7295-4B6A-B72E-5E6AA2DDA775 Q37688197-37977094-C56B-46CC-8C97-8BCBC4E8FFB0 Q38261856-B9590B86-EFF8-40D6-8502-D7BD50EB254A Q38387142-085C6B30-579E-43B7-976A-2DF94CD39288 Q38387844-1178B6DB-C93D-4447-83A0-737B4DCE90E6 Q38405944-271515F1-491D-4EBF-9274-A1D3A42EEFAE Q38547110-6E3682A8-6397-4A89-B3C9-9AC93815EA30 Q38607644-A16BCB3B-337B-482F-9621-937B5BE4E6C8 Q38628753-27111164-3F98-4C2F-9EE4-9C25A23D306C Q38668635-C744CAB3-AF8C-4F24-AE91-8B169042F8E8 Q38678110-AFD88AFB-F70D-4289-B617-F591944A0660 Q38717262-3DB7AFF8-FB7F-404E-811A-274C4F97F37F Q38730590-FA79FD52-A412-4942-81A0-4C44B0744914 Q38806777-E27D49B3-51BE-4C13-AC7E-66074707C22F Q39031157-C718647C-099A-4EF9-B516-622737FFD3AA Q39457456-FF5B0C80-25DA-4091-A95D-8D74738E6942 Q39581362-97E7F96D-FDAD-49E6-90A0-D85196C2332E Q41899048-136B7220-C15E-4714-B720-55D5547EAE8D Q42096361-5A1D2E0C-5F51-4BD7-9817-6A68D854D908 Q42288618-F0324174-6606-496E-ADF0-080B35E9E325 Q42378445-D9943FE6-5443-4490-BD81-8D924E56D1AD Q47100389-650EB619-BEE3-4A62-B756-0AB93A5BB72D Q49557521-811C39F1-BC67-4F8E-88BF-C2177C236051 Q50317499-7ACDC2B9-BC2A-4A9D-B346-FF4349BD0699 Q52714347-9A56D131-DE9C-4B3D-98B1-BD893034F455

P2860

Circulating tumour cells-monitoring treatment response in prostate cancer.

http://www.wikidata.org/entity/Q38211361

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Circulating tumour cells-monitoring treatment response in prostate cancer.

@en

type

label

Circulating tumour cells-monitoring treatment response in prostate cancer.

@en

prefLabel

Circulating tumour cells-monitoring treatment response in prostate cancer.

@en

P1433

Q38211361-64D9A61C-9B3B-4755-91B7-081AC1FFC409

P1476

Q38211361-C9F2F8ED-4C20-4A70-B155-83DA33848804

P2093

Q38211361-4052E3A2-18AE-4D12-9E44-9B3CBCDBA4EC

Q38211361-7BDC4AC5-2CF3-4030-A4EC-C9AB92A026AC

Q38211361-857264FD-9291-4619-BF77-AA38476E9C34

P2860

Q38211361-019DF62A-A6B9-4EF6-8DA8-6CA1F3F59585

Q38211361-0237010F-3212-425C-825D-970EE0F81543

Q38211361-064F1F0C-F061-4181-B4DF-FDD2BF2C9497

Q38211361-09BF856C-62FC-4DB9-89B8-55FF33A3BACA

Q38211361-0B8FD67E-11DE-4963-BCBF-17CCA45B700D

Q38211361-0C0025A2-EDCF-4268-9B6A-F76258DB4350

Q38211361-0DAB51AE-3298-4B0F-A98A-7B02D4D97B89

Q38211361-10BE1C0E-DE02-44FD-9CF7-8BDECB6C4B10

Q38211361-13430604-FFA1-4E95-B6F0-B1A518B78F3C

Q38211361-13592400-F6A6-4D60-9617-5D6C6385418E

P304

Q38211361-C0295C55-E174-4988-9B0A-8C97931024AF

P31

Q38211361-11C35704-DD9C-44FD-AF4A-62004843AE73

P356

Q38211361-FB491F09-9138-4133-B7A0-8868A6AFC412

P407

Q38211361-ED5CEFB4-FF44-46FC-8A75-FE49E151427B

P433

Q38211361-FFD77C0B-8E20-4292-B646-0F87DFA028B0

P478

Q38211361-D96F9F08-70F1-4798-80A9-FF8172603D1A

P577

Q38211361-BB152BFA-B89A-46DD-964C-154B6B138167

P698

Q38211361-DBE5F51A-41EA-4F7A-A56C-5A6E8F1F0835

P356

NRCLINONC.2014.82

P1433

Nature Reviews Clinical Oncology

P1476

Circulating tumour cells-monitoring treatment response in prostate cancer.

@en

P2093

David T Miyamoto

http://www.w3.org/2001/XMLSchema#string

Lecia V Sequist

http://www.w3.org/2001/XMLSchema#string

Richard J Lee

http://www.w3.org/2001/XMLSchema#string

P2860

Isolation of rare circulating tumour cells in cancer patients by microchip technology

Abiraterone in metastatic prostate cancer without previous chemotherapy

Circulating tumor cells: approaches to isolation and characterization

Fluid biopsy in patients with metastatic prostate, pancreatic and breast cancers

Sipuleucel-T immunotherapy for castration-resistant prostate cancer

Cancer statistics, 2014

Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases

Functional characterization of circulating tumor cells with a prostate-cancer-specific microfluidic device

Single cell profiling of circulating tumor cells: transcriptional heterogeneity and diversity from breast cancer cell lines

Unbiased and automated identification of a circulating tumour cell definition that associates with overall survival

P304

401-412

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NRCLINONC.2014.82

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P577

2014-05-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24821215

http://www.w3.org/2001/XMLSchema#string